BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9736261)

  • 1. Regulation of renal function by prostaglandin E receptors.
    Breyer MD; Zhang Y; Guan YF; Hao CM; Hebert RL; Breyer RM
    Kidney Int Suppl; 1998 Sep; 67():S88-94. PubMed ID: 9736261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE
    Deen PMT; Boone M; Schweer H; Olesen ETB; Carmone C; Wetzels JFM; Fenton RA; Kortenoeven MLA
    Front Physiol; 2021; 12():787598. PubMed ID: 35126177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 receptors as therapeutic targets in renal fibrosis.
    Mutsaers HAM; Nørregaard R
    Kidney Res Clin Pract; 2022 Jan; 41(1):4-13. PubMed ID: 35108767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EP
    Kresse JC; Mutsaers HAM; Jensen MS; Tingskov SJ; Madsen MG; Nejsum LN; Praetorius H; Nørregaard R
    Acta Physiol (Oxf); 2022 Mar; 234(3):e13780. PubMed ID: 34989478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 15-PGDH prevents ischemic renal injury by the PGE
    Kim HJ; Kim SH; Kim M; Baik H; Park SJ; Kang MS; Kim DH; Kim BW; Markowitz SD; Bae KB
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1054-F1066. PubMed ID: 33135478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between EP2 and PPARα Modulates Hypoxic Signaling and Myopia Development in Guinea Pigs.
    Srinivasalu N; Zhang S; Xu R; Reinach PS; Su Y; Zhu Y; Qu J; Zhou X
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):44. PubMed ID: 32725213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the prostaglandin E
    Jensen MS; Mutsaers HAM; Tingskov SJ; Christensen M; Madsen MG; Olinga P; Kwon TH; Nørregaard R
    Acta Physiol (Oxf); 2019 Sep; 227(1):e13291. PubMed ID: 31054202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice.
    Declèves AE; Mathew AV; Armando AM; Han X; Dennis EA; Quehenberger O; Sharma K
    J Lipid Res; 2019 May; 60(5):937-952. PubMed ID: 30862696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney.
    Nørregaard R; Kwon TH; Frøkiær J
    Kidney Res Clin Pract; 2015 Dec; 34(4):194-200. PubMed ID: 26779421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.
    Imig JD; Khan MA
    Compr Physiol; 2015 Dec; 6(1):423-41. PubMed ID: 26756638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloride secretion by renal collecting ducts.
    Rajagopal M; Wallace DP
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):444-9. PubMed ID: 26125646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.
    Gao M; Cao R; Du S; Jia X; Zheng S; Huang S; Han Q; Liu J; Zhang X; Miao Y; Kang J; Gustafsson JÅ; Guan Y
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8397-402. PubMed ID: 26100911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal autoregulation in health and disease.
    Carlström M; Wilcox CS; Arendshorst WJ
    Physiol Rev; 2015 Apr; 95(2):405-511. PubMed ID: 25834230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of the prostaglandin E2 EP1 receptor in MDCK cells increases growth through activation of Akt and the epidermal growth factor receptor.
    Taub M; Parker R; Mathivanan P; Ariff MA; Rudra T
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F539-50. PubMed ID: 25007872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of prostaglandin E2 receptor subtype 1 (ep 1 ) in Bostrichthys sinensis.
    Lai XJ; Hong WS; Liu F; Zhang YT; Chen SX
    Fish Physiol Biochem; 2014 Aug; 40(4):1281-8. PubMed ID: 24566823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of prostaglandins and cyclooxygenase-2 inhibitors.
    Kim GH
    Electrolyte Blood Press; 2008 Jun; 6(1):35-41. PubMed ID: 24459520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 mediates connecting tubule glomerular feedback.
    Ren Y; D'Ambrosio MA; Garvin JL; Wang H; Carretero OA
    Hypertension; 2013 Dec; 62(6):1123-8. PubMed ID: 24060896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylyl cyclase VI mediates vasopressin-stimulated ENaC activity.
    Roos KP; Bugaj V; Mironova E; Stockand JD; Ramkumar N; Rees S; Kohan DE
    J Am Soc Nephrol; 2013 Feb; 24(2):218-27. PubMed ID: 23264685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia.
    Liu Y; Rajagopal M; Lee K; Battini L; Flores D; Gusella GL; Pao AC; Rohatgi R
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1425-34. PubMed ID: 22933297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of prostaglandin E1 and E2 on vascular reactivity and blood flow in situ in the chick chorioallantoic membrane.
    Harland DR; Lorenz LD; Fay K; Dunn BE; Gruenloh SK; Narayanan J; Jacobs ER; Medhora M
    Prostaglandins Leukot Essent Fatty Acids; 2012; 87(2-3):79-89. PubMed ID: 22858445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.